|
000
| 01253cam 2200313zi 4500 |
|---|
| 001 | 9.889905 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107172430 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 200728s1979 onc o f000 0|eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aRG36-5/1979E-PDF |
|---|
| 100 | 1 |aEllis, E. D., |eauthor. |
|---|
| 245 | 10|aMarket share effects of compulsory licensing / |cE.D. Ellis. |
|---|
| 264 | 1|a[Ottawa] : |bBureau of Corporate Affairs, Consumer and Corporate Affairs, |c[1979] |
|---|
| 300 | |a1 online resource (3, 94 unnumbered pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aDigitized edition from print [produced by Innovation, Science and Economic Development Canada]. |
|---|
| 650 | 0|aCompulsory licensing of patents|zCanada. |
|---|
| 650 | 0|aDrugs|zCanada|xPatents. |
|---|
| 650 | 6|aLicence obligatoire des brevets d'invention|zCanada. |
|---|
| 650 | 6|aMédicaments|zCanada|xBrevets d'invention. |
|---|
| 710 | 1 |aCanada. |bConsumer and Corporate Affairs, |eissuing body. |
|---|
| 856 | 40|qPDF|s1.26 MB|uhttps://publications.gc.ca/collections/collection_2022/isde-ised/RG36-5-1979-eng.pdf |
|---|